Vifor

MIRCERA

Manufacturer:

Vifor

Mircera HCPCS:

J0887

HCPCS Code Descriptor:

Injection, epoetin beta, 1 microgram, (for esrd on dialysis)

Category:

J Code

Mircera NDCs:

59353-0401-09, 59353-0400-09, 59353-0402-09, 59353-0407-09, 59353-0405-09, 59353-0403-09, 59353-0404-09

Primary Type:

Oncology Colony Stimulating Factor

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

59353-0407-09

About Mircera:

MIRCERA is an Oncology Colony Stimulating Factor drug manufactured by Vifor and administered via the Intravenous route of administration. The J Code: J0887 is aligned to the drug MIRCERA.

ACCESS PRICING AND MORE BY REGISTERING

J0887 Added Date:

January 1, 2015

J0887 Effective Date:

January 1, 2023

J0887 Termination Date:

HCPCS Active

Mircera billing and coding information can be found through Vifor at the link below:
Our team did not identify a source for Mircera patient assistance information. Please reach out to our team if you feel that this is a mistake.
MIRCERA prescribing information can be found at the link below:
Information regarding MIRCERA’s side effects can be found at MedlinePlus